مقایسهٔ روشها
روشهای انتخابی خود را کنار هم مرور کنید؛ ردیفهای متفاوت برجسته شدهاند.
| EORTC QLQ-BR23: کیفیت زندگی در سرطان پستان× | مقیاس نگرانی سرطان: سنجش پریشانی روانی در مراقبتهای سرطان× | |
|---|---|---|
| حوزه | سرطانشناسی | سرطانشناسی |
| خانواده | Process / pipeline | Process / pipeline |
| سال پیدایش≠ | 1996 | 1991 |
| پدیدآور≠ | Sprangers, M. A., et al. (EORTC Quality of Life Group) | Lerman, C., et al. |
| نوع | Self-report questionnaire | Self-report questionnaire |
| منبع بنیادین≠ | Sprangers, M. A., Groenvold, M., Arraras, J. I., Franklin, J., te Velde, A., Muller, M., et al. (1996). The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study. J Clin Oncol, 14(10), 2756–2768. DOI ↗ | Lerman, C., Trock, B., Rimer, B. K., Jepson, C., Brody, D., & Boyce, A. (1991). Psychological side effects of breast cancer screening. Health Psychol, 10(1), 259–267. DOI ↗ |
| نامهای دیگر | QLQ-BR23 | CWS |
| مرتبط | 5 | 5 |
| خلاصه≠ | The EORTC QLQ-BR23 is a 23-item breast-cancer-specific module designed to complement the 30-item EORTC QLQ-C30 core questionnaire, assessing functional and symptom domains unique to breast cancer. Validated by Sprangers et al. in 1996, it measures body image, sexual function, breast symptoms, and arm symptoms, making it a standard instrument in European and international breast cancer clinical trials and quality-of-life research. | The Cancer Worry Scale (CWS) is a brief 8-item instrument assessing the degree to which cancer-related worry interferes with daily functioning and emotional well-being. Developed by Lerman et al. in 1991, it quantifies cancer-related anxiety and distress—psychological burden distinct from symptom burden and functional impairment. It is widely used in cancer screening, treatment, and survivorship contexts to identify patients requiring psychological support. |
| ScholarGateمجموعهداده ↗ |
|
|